These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12756314)

  • 1. Charcot-Marie-Tooth disease and vincristine.
    Orejana-García AM; Pascual-Huerta J; Pérez-Melero A
    J Am Podiatr Med Assoc; 2003; 93(3):229-33. PubMed ID: 12756314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
    Neumann Y; Toren A; Rechavi G; Seifried B; Shoham NG; Mandel M; Kenet G; Sharon N; Sadeh M; Navon R
    Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E; Poulton J; Buck J; Broadbent V; Bamford M; Jungbluth H; Manzur AY; Muntoni F
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.
    Aghajan Y; Yoon JM; Crawford JR
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28438772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ; Bordeaux B; Leshner RT
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.
    Weimer LH; Podwall D
    J Neurol Sci; 2006 Mar; 242(1-2):47-54. PubMed ID: 16386273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R; Mohm J; Reuner U; Kroschinsky F; Rautenstrauss B; Ehninger G
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment.
    Kalfakis N; Panas M; Karadima G; Floroskufi P; Kokolakis N; Vassilopoulos D
    Neurology; 2002 Nov; 59(9):1470-1. PubMed ID: 12427913
    [No Abstract]   [Full Text] [Related]  

  • 11. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).
    Igarashi M; Thompson EI; Rivera GK
    Med Pediatr Oncol; 1995 Aug; 25(2):113-6. PubMed ID: 7603395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are platinum-based chemotherapeutic drugs safe for patients with Charcot-Marie-Tooth disease?
    Yerushalmi R; Levi I; Wygoda M; Ifergane G; Wirguin I
    J Peripher Nerv Syst; 2007 Jun; 12(2):139-41. PubMed ID: 17565539
    [No Abstract]   [Full Text] [Related]  

  • 14. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD; Smith AA; Odom LF
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature.
    Sy A; Cheng J; Cooper R; Mueller L
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e41-e43. PubMed ID: 29877907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS; Riggs JE
    Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
    Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anterior ankle-foot orthosis improves walking economy in Charcot-Marie-Tooth type 1A patients.
    Menotti F; Laudani L; Damiani A; Mignogna T; Macaluso A
    Prosthet Orthot Int; 2014 Oct; 38(5):387-92. PubMed ID: 24100074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome.
    Hogan-Dann CM; Fellmeth WG; McGuire SA; Kiley VA
    JAMA; 1984 Nov 23-30; 252(20):2862-3. PubMed ID: 6092732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.